A Phase I Clinical Study of Intratumoral Injection GC001 in Patient With Recurrent or Progressive Gliomas

Clinical trial NCT06660056 · RECRUITING

Trial details

NCT number: NCT06660056
Sponsor: GONGCHU Biotechnology Co., Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

High-grade Gliomas

Start date: 2024-10-08
Primary completion: 2026-02-08
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.